ABU DHABI / GULF TIME ADCOOP – the UAE’s community-centered retail destination – is proud ...
Read More »AstraZeneca cancer drug gets first Japan approval
Bloomberg AstraZeneca Plc’s new drug Imjudo won approval in Japan for two different cancer types when added to the blockbuster medicine Imfinzi, widening the immune therapy’s reach. The treatment, a monoclonal antibody, is now authorised for forms of lung and liver cancer in Japan for patients who are also receiving Imfinzi, Astra said. The approval, coming after clearance in ...
Read More »